324 related articles for article (PubMed ID: 21351727)
21. pH-enzyme di-dependent chronotherapeutic drug delivery system of theophylline for nocturnal asthma.
Soni ML; Namdeo KP; Jain SK; Gupta M; Dangi JS; Kumar M; Dangi YS
Chem Pharm Bull (Tokyo); 2011; 59(2):191-5. PubMed ID: 21297298
[TBL] [Abstract][Full Text] [Related]
22. Potential of calcium pectinate beads for target specific drug release to colon.
Jain A; Gupta Y; Jain SK
J Drug Target; 2007 May; 15(4):285-94. PubMed ID: 17487697
[TBL] [Abstract][Full Text] [Related]
23. Controlled release of tamoxifen citrate encapsulated in cross-linked guar gum nanoparticles.
Sarmah JK; Mahanta R; Bhattacharjee SK; Mahanta R; Biswas A
Int J Biol Macromol; 2011 Oct; 49(3):390-6. PubMed ID: 21641924
[TBL] [Abstract][Full Text] [Related]
24. Graft polymerization of guar gum with acryl amide irradiated by microwaves for colonic drug delivery.
Shahid M; Bukhari SA; Gul Y; Munir H; Anjum F; Zuber M; Jamil T; Zia KM
Int J Biol Macromol; 2013 Nov; 62():172-9. PubMed ID: 23973495
[TBL] [Abstract][Full Text] [Related]
25. Guar gum/ethylcellulose coated pellets for colon-specific drug delivery.
Ji CM; Xu HN; Sun NY; Lu YP; Wu W
Yao Xue Xue Bao; 2007 Jun; 42(6):656-62. PubMed ID: 17702405
[TBL] [Abstract][Full Text] [Related]
26. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets.
Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
Eur J Pharm Sci; 2003 Aug; 19(5):355-62. PubMed ID: 12907286
[TBL] [Abstract][Full Text] [Related]
27. Prospective of guar gum and its derivatives as controlled drug delivery systems.
Prabaharan M
Int J Biol Macromol; 2011 Aug; 49(2):117-24. PubMed ID: 21596058
[TBL] [Abstract][Full Text] [Related]
28. [Study on modified guar gum microsphere as a protein drug carrier].
Ou F; Zhang L; Chen R
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Dec; 23(6):1267-70. PubMed ID: 17228723
[TBL] [Abstract][Full Text] [Related]
29. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
Rai G; Yadav AK; Jain NK; Agrawal GP
Drug Deliv; 2016; 23(1):328-37. PubMed ID: 24845476
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
31. Compression coated systems for colonic delivery of 5-fluorouracil.
Sinha VR; Singh A; Singh S; Bhinge JR
J Pharm Pharmacol; 2007 Mar; 59(3):359-65. PubMed ID: 17331338
[TBL] [Abstract][Full Text] [Related]
32. Design of phosphated cross-linked microspheres of bael fruit gum as a biodegradable carrier.
Mahammed N; Gowda DV; Deshpande RD; Thirumaleshwar S
Arch Pharm Res; 2015 Jan; 38(1):42-51. PubMed ID: 24668152
[TBL] [Abstract][Full Text] [Related]
33. Guar gum succinate-sodium alginate beads as a pH-sensitive carrier for colon-specific drug delivery.
Seeli DS; Dhivya S; Selvamurugan N; Prabaharan M
Int J Biol Macromol; 2016 Oct; 91():45-50. PubMed ID: 27212216
[TBL] [Abstract][Full Text] [Related]
34. Polymeric Microsphere Formulation for Colon Targeted Delivery of 5-Fluorouracil Using Biocompatible Natural Gum Katira.
Karan S; Choudhury H; Chakra BK; Chatterjee TK
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2181-2194. PubMed ID: 31350983
[TBL] [Abstract][Full Text] [Related]
35. Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.
Lai H; Lin K; Zhang W; Zhang Z; Jie L; Wu Y; He Q
Drug Dev Ind Pharm; 2010 Jan; 36(1):81-92. PubMed ID: 19640246
[TBL] [Abstract][Full Text] [Related]
36. Interpenetrating polymer network of locust bean gum-poly (vinyl alcohol) for controlled release drug delivery.
Kaity S; Isaac J; Ghosh A
Carbohydr Polym; 2013 Apr; 94(1):456-67. PubMed ID: 23544563
[TBL] [Abstract][Full Text] [Related]
37. Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancer.
Haupt S; Zioni T; Gati I; Kleinstern J; Rubinstein A
Eur J Pharm Sci; 2006 Jun; 28(3):204-11. PubMed ID: 16581235
[TBL] [Abstract][Full Text] [Related]
38. Formulation development and in-vitro/in-vivo correlation for a novel Sterculia gum-based oral colon-targeted drug delivery system of azathioprine.
Nath B; Nath LK
Drug Dev Ind Pharm; 2013 Nov; 39(11):1765-73. PubMed ID: 23110370
[TBL] [Abstract][Full Text] [Related]
39. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.
Rai G; Jain SK; Agrawal S; Bhadra S; Pancholi SS; Agrawal GP
Pharmazie; 2005 Feb; 60(2):131-4. PubMed ID: 15739902
[TBL] [Abstract][Full Text] [Related]
40. Utilizing guar gum for development of "tabs in cap' system of losartan potassium for chronotherapeutics.
Gangwar G; Kumar A; Pathak K
Int J Biol Macromol; 2015 Jan; 72():812-8. PubMed ID: 25268456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
